RCS - Iofina PLC - Investor Presentation

IofinaAnnouncement

04/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230504:nRSD3428Ya&default-theme=true

RNS Number : 3428Y  Iofina PLC  04 May 2023

RNS Reach

04 May 2023

Iofina plc

(Iofina or the 'Company' or the 'Group')

Investor Presentation

Iofina plc (AIM:IOF), specialists in the exploration and production of iodine
and manufacturers of specialty chemical products, announces that Dr. Tom
Becker, Chief Executive Officer and Malcolm Lewin, Chief Financial officer,
will hold an investor presentation and Q&A session on Thursday, 11 May
2023 at 1:30pm (BST) via the Investor Meet Company platform.

 

The presentation will relate to the Group's preliminary results for the twelve
months ended 31 December 2022, which was announced on Tuesday, 25 April
2023.

 

The presentation is open to all existing and potential shareholders. Investors
can sign up to Investor Meet Company for free on:

https://www.investormeetcompany.com/iofina-plc/register-investor
(https://www.investormeetcompany.com/iofina-plc/register-investor)

Investors who already follow Iofina on the Investor Meet Company platform
will automatically be invited.

·     Investors are encouraged to submit questions pre-event via the "Ask
a Question" function located on the Investor Meet Company dashboard up
until 9 am the day before the meeting or at any time during the live
presentation.

·     Whilst the Company will not be in a position to answer every
question it receives, it will address the most prominent within the confines
of information already disclosed to the market through regulatory
notifications.

·     Responses to the Q&A will be published at the earliest
opportunity on the Investor Meet Company platform following the
presentation.

·     Investor feedback can also be submitted directly to management post
the event to ensure the Company can understand the views of all elements of
its shareholder base.

For further information, please email: iofina@yellowjerseypr.com
(mailto:iofina@yellowjerseypr.com)

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Henry Fitzgerald-O'Connor/Patrick Dolaghan/Andrew Potts

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

 

Financial Adviser:

Kingsley Wilson

Chrystal Capital Partners LLP

Tel: +44 (0)20 7850 4761

 

Media Contact:

Charles Goodwin/Shivantha Thambirajah/Jazmine Clemens

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

 

Notes to Editors

 

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

 

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates five
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products.  Iofina
Chemical will be celebrating its 40(th) anniversary in 2023 as a preeminent
halogen-based specialty chemicals company.

 

www.iofina.com (http://www.iofina.com/)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUORKROSUVRAR